Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2013
11/26/2013US8591903 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation
11/26/2013US8591901 Antibodies to TGF-β
11/26/2013US8591897 Anti-ERBB2 antibody adjuvant therapy
11/26/2013US8591863 Compositions against cancer antigen LIV-1 and uses thereof
11/26/2013CA2745998C Biomarkers for diagnosing alzheimer's disease
11/26/2013CA2718802C Recombinant nucleic acids comprising regions of ad6
11/26/2013CA2631716C Targeting vector-phospholipid conjugates
11/26/2013CA2618374C Trimeric collagen scaffold antibodies
11/26/2013CA2561565C Methods for repression of phospholamban gene and modulating cardiac contractility
11/26/2013CA2539996C Prevention of incorporation of non-standard amino acids into protein
11/26/2013CA2511538C Immunostimulatory combinations
11/26/2013CA2482744C Hiv envelope-cd4 complexes and hybrids
11/26/2013CA2450710C Methods for the simultaneous detection of hcv antigens and hcv antibodies
11/26/2013CA2443223C Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/26/2013CA2425072C Wt1 fusion polypeptides and methods for wt1 immunotherapy
11/26/2013CA2334850C Novel methods and interferon deficient substrates for the propagation of viruses
11/26/2013CA2279231C Activity dependent neurotrophic factor iii (adnf iii)
11/25/2013CA2815869A1 Method of determining the genotype relating to hereditary nasal parakeratosis (hnpk) and nucleic acids usable in said method
11/21/2013WO2013173807A1 Improved mobilization of hematopoetic stem cells from bone marrow to blood using a combination of a robo4 receptor antagonist and a cxcr4 antagonist or hrvegf-165 and a cxcr4 antagonist
11/21/2013WO2013173706A2 Huwentoxin-iv variants and methods of use
11/21/2013WO2013173678A1 COMPOSITIONS WHICH REGULATE THE EPITHELIAL BRUSH BORDER Na+/H+ EXCHANGER NHE3 AND THEIR METHODS OF USE IN GASTROINTESTINAL DISEASE
11/21/2013WO2013173590A1 Vaccines for hsv-2
11/21/2013WO2013173348A1 Cross-reactive antibodies against dengue virus and uses thereof
11/21/2013WO2013172701A1 Fusion proteins capable of both ph and temperature induced self-assembly into nanocapsules
11/21/2013WO2013172421A1 Ampk protein activator screening method, and ampk protein activator
11/21/2013WO2013172105A1 Marker for detecting pancreatic cancer
11/21/2013WO2013171810A1 Method for obtaining heat-resistant antibody-presenting phage
11/21/2013WO2013171595A1 Novel compounds and methods for inhibiting cell death
11/21/2013WO2013171268A1 Allergen variants
11/21/2013WO2013170636A1 Protein and protein conjugate for diabetes treatment, and applications thereof
11/21/2013WO2013170399A1 Cotton plant event a2-6 and primer and method for use in detection thereof
11/21/2013WO2013170398A1 Cotton plant event a26-5 and primer and method for use in detection thereof
11/21/2013WO2013152264A3 Proteins toxic to hemipteran insect species
11/21/2013WO2013138522A3 Methods for assessing effectiveness and monitoring oncolytic virus treatment
11/21/2013WO2013138289A3 Genetic reduction of male fertility in plants
11/21/2013WO2013134577A3 Leishmaniasis antigen detection assays and vaccines
11/21/2013WO2013113916A3 Ghrelin analogues
11/21/2013WO2013107526A3 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
11/21/2013WO2012142245A8 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
11/21/2013US20130310540 Extract of aquatic animal cartilage
11/21/2013US20130310539 Glycation Cross-link Breakers to Increase Resistance to Enzymatic Degradation
11/21/2013US20130310538 Methods and compositions for delivering active agents with enhanced pharmacological properties
11/21/2013US20130310443 Aav vectors with high transduction efficiency and uses thereof for gene therapy
11/21/2013US20130310324 Huwentoxin-iv variants and methods of use
11/21/2013US20130310317 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
11/21/2013US20130310313 Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
11/21/2013US20130310306 Human lactoferrin derived peptides and their use
11/21/2013US20130310304 Compositions and methods for the treatment of atherosclerosis
11/21/2013US20130310302 Protective hydrocolloid for active ingredients
11/21/2013US20130310271 Tuberculosis diagnostic test
11/21/2013US20130309766 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
11/21/2013US20130309765 Modified tamavidin
11/21/2013US20130309720 Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs
11/21/2013US20130309691 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto
11/21/2013US20130309268 Compositions including transfer factor derived from eggs
11/21/2013US20130309264 Novel antigen of enterococcal pathogens and use therof as vaccine component for therapy and/or prophylaxis
11/21/2013US20130309262 Hsv-1 epitopes and methods for using same
11/21/2013US20130309260 Human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
11/21/2013US20130309253 Cancer treatment with endothelin receptor antagonists
11/21/2013US20130309232 Vascular endothelial growth factor 2
11/21/2013US20130309231 Methods for using taci-immunoglobulin fusion proteins
11/21/2013US20130309179 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with porphyromonas gingivalis
11/21/2013DE102004043153B4 Erfindung betreffend GLP-1 und Exendin Invention concerning GLP-1 and exendin
11/20/2013EP2664624A1 Allergen variants
11/20/2013EP2664622A2 Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
11/20/2013EP2664344A1 Ehrlichia canis diva (differentiate infection from vaccinated animals)
11/20/2013EP2664343A2 Suppression of cancer
11/20/2013EP2664342A2 Native (telopeptide) placental collagen compositions
11/20/2013EP2664341A2 Native (telopeptide) placental collagen compositions
11/20/2013EP2664337A1 Amniotic membrane preparations and purified compositions and methods of use
11/20/2013EP2663868A2 Methods and compositions for targeting sites of neovascular growth
11/20/2013EP2663633A1 Filamentous fungi having an altered viscosity phenotype
11/20/2013EP2663576A2 Novel wnt compositions and therapeutic uses of such compositions
11/20/2013EP2663575A1 Humanized il-6 and il-6 receptor
11/20/2013EP2663336A1 Methods and reagents for efficient and targeted delivery of therapeutic molecules to cxcr4 cells
11/20/2013EP2371847B1 Peptides and their derived type APL of the HSP60 and pharmaceutical compositions
11/20/2013EP2345667B1 A method for producing an L-amino acid using a bacterium of the enterobacteriaceae family
11/20/2013EP2300609B1 Novel immunoadjuvant flagellin-based compounds and use thereof
11/20/2013EP2261327B1 A group of novel enantioselective microbial nitrile hydratases with broad substrate specificity
11/20/2013EP2235052B1 Proteinaceous binding molecules comprising purification tags
11/20/2013EP2207885B1 Quadruple transgenic non-human animal
11/20/2013EP2179042B1 Late blight resistance genes and methods
11/20/2013EP2142644B1 Mutated hyperthermophilic phosphotriesterases and uses thereof
11/20/2013EP2130921B1 Vaccine for prevention and treatment of HIV-infection
11/20/2013EP2129685B1 Over expression of foldases and chaperones improves protein production
11/20/2013EP2078038B1 Reconstituted surfactants having improved properties
11/20/2013EP2075334B1 EG-VEGF nucleic acids and polypeptides and methods of use
11/20/2013EP1891091B1 Coagulation factor x polypeptides with modified activation properties
11/20/2013EP1885747B1 Erythropoietin variants
11/20/2013EP1694347B1 Glycopegylated erythropoietin
11/20/2013EP1662004B1 Method of preparing a proliferation-regulated recombinant adenoviral vector, kit and vector
11/20/2013EP1565203B1 Templated native silk smectic gels
11/20/2013EP1518558B1 Vaccine against infection with Actinobacillus pleuropneumoniae comprising purified ApxIV toxin
11/20/2013CN1989250B Tc-83-derived alphavirus vectors, particles and methods
11/20/2013CN1832956B Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/20/2013CN103403154A Protein secretion
11/20/2013CN103403024A Improved N-terminal capping modules for designed ankyrin repeat proteins
11/20/2013CN103403023A Inhibitors of apoptosis and uses thereof
11/20/2013CN103403022A Plant gene expression modulatory sequences from maize
11/20/2013CN103403021A Transgenic plants
1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 2916